Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

NCT01676506 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: Ranibizumab
PROCEDURE: Ranibizumab Injection

Sponsor

Russian Academy of Medical Sciences